Candel Therapeutics Inc
NASDAQ:CADL

Watchlist Manager
Candel Therapeutics Inc Logo
Candel Therapeutics Inc
NASDAQ:CADL
Watchlist
Price: 4.85 USD Market Closed
Market Cap: 243m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CADL.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CADL Intrinsic Value
Not Available
Base Case Scenario
Compare CADL to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CADL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Candel Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Candel Therapeutics Inc

Current Assets 93.1m
Cash & Short-Term Investments 92.2m
Other Current Assets 983k
Non-Current Assets 2.8m
PP&E 2.4m
Other Non-Current Assets 324k
Efficiency

Free Cash Flow Analysis
Candel Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Candel Therapeutics Inc

Revenue
0 USD
Operating Expenses
-33.6m USD
Operating Income
-33.6m USD
Other Expenses
-6m USD
Net Income
-39.6m USD
Fundamental Scores

CADL Profitability Score
Profitability Due Diligence

Candel Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Candel Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

CADL Solvency Score
Solvency Due Diligence

Candel Therapeutics Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
70/100
Solvency
Score

Candel Therapeutics Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CADL Price Targets Summary
Candel Therapeutics Inc

Wall Street analysts forecast CADL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CADL is 21.42 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
212% Upside
Average
Price Target
21.42 USD
342% Upside
Highest
Price Target
26.25 USD
441% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Candel Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CADL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CADL Insider Trading
Buy and sell transactions by insiders

CADL News